Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Research Applications (laboratory / non-clinical research only) In vitro studies of copper peptide influence on fibroblast activity and collagen-related gene expression Animal model research into dermal matrix composition and connective tissue remodeling Preclinical investigation of copper-dependent antioxidant enzyme pathways, including superoxide dismutase activity Comparative research alongside other copper-binding peptides such as GHK-Cu in laboratory settings Cell culture studies examining peptide stability and copper ion delivery mechanisms Quality & Sourcing AHK-Cu 100mg peptide research material is synthesized to high purity standards and verified by HPLC (High-Performance Liquid Chromatography) analysis
With fewer red blood cells to carry oxygen, your heart and lungs may work harder, which can lead to breathlessness or a faster heartbeat
Does it have completed human trials behind it
US$ 24.21
US$ 20.97
US$ 20.05
US$ 25.11
